OrbusNeich Medical Group Ltd (HKG: 6929), a Wholly Owned Foreign Enterprise (WOFE) specializing in vascular intervention based in Shenzhen, is poised to acquire an 84% stake in Indonesia-headquartered PT Revass Utama Medika for a consideration between USD 10.08 million to USD 20.16 million.
PT Revass Utama Medika, which is focused on the marketing and distribution of cardiovascular intervention, neurological intervention, peripheral intervention, and continuous renal replacement therapy products, has been OrbusNeich’s sole local device distributor prior to this transaction.- Flcube.com
